| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |